STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRAX
  4. [8-K] Praxis Precision Medicines, Inc. Reports Material Event

[8-K] Praxis Precision Medicines, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock PRAX logo
Praxis Precision Medicines, Inc.

NASDAQ:PRAX

PRAX Rankings

#3786 Ranked by Market Cap
N/A Ranked by Dividends
#23 Top Gainer

PRAX Latest News

Jul 17, 2025
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Jul 2, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 4, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2025
Praxis Precision Medicines to Participate in Upcoming Conferences
May 5, 2025
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event

PRAX Latest SEC Filings

Jun 27, 2025
[8-K] Praxis Precision Medicines, Inc. Reports Material Event
Jun 27, 2025
[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity
Jun 27, 2025
[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity
Jun 27, 2025
[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity
Jun 27, 2025
[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity

PRAX Stock Data

1.02B
19.34M
0.46%
108.65%
9.03%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON